A New Tool to Promote Patient's Engagement in Their Healthcare Process
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEuropean Institute of Oncology
About this trial
Women diagnosed with early-stage breast cancer need to make a decision about the therapeutic treatment to undertake. Since multiple factors can influence this decision, it is necessary to develop a decision-making support tool to assist them in making this choice.
Main Objective: To develop a decision-making support tool for determining the treatment to undertake for women diagnosed with early-stage breast cancer and test its effectiveness on an experimental group.
Eligibility criteria
Qualifiers
be 18 or older;
have received/receive diagnosis of resectable breast cancer in the early stage;
women treated or who will undergo oncological treatment for early breast cancer;
demonstrate the absence of psychopathological features.
Disqualifiers
breast cancer patients who showed physical or psychological issues, as well as cognitive impairments that prohibited their participation in this type of study;
neurological or psychiatric disorders that may compromise the patients' ability to take part in the study.
Distant metastases from breast cancer or locally advanced/unresectable disease
Known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
Trial design
Treatments tested in this trial
- Healthcare professionals
- Patients PDA group
- Patients control group
Treatment groups
180 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov